A rapid CRISPR competitive assay for in vitro and in vivo discovery of potential drug targets affecting the hematopoietic system-Reference-Cited by-同舟云学术

A rapid CRISPR competitive assay for in vitro and in vivo discovery of potential drug targets affecting the hematopoietic system

Published:2021 Issue: Volume:19 Page:5360-5370
ISSN:2001-0370
Container-title:Computational and Structural Biotechnology Journal
language:en
Short-container-title:Computational and Structural Biotechnology Journal

Author:

Shen Yunbing^ORCID,Jiang Long^ORCID,Iyer Vaishnavi Srinivasan,Raposo Bruno^ORCID,Dubnovitsky Anatoly^ORCID,Boddul Sanjaykumar V.,Kasza Zsolt^ORCID,Wermeling Fredrik^ORCID

Funder

Vetenskapsradet

Publisher

Elsevier BV

Subject

Computer Science Applications,Genetics,Biochemistry,Structural Biology,Biophysics,Biotechnology

Reference53 articles.

1. Multiplex genome engineering using CRISPR/Cas systems;Cong;Science,2013

2. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity;Jinek;Science,2012

3. RNA-guided human genome engineering via Cas9;Mali;Science,2013

4. Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants;Makarova;Nat Rev Microbiol,2020

5. Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells;Hendel;Nat Biotechnol,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRISPR/Cas9-mediated gene disruption determines the roles of MITF and CITED2 in human mast cell differentiation;Blood Advances;2024-07-25

2. Dnmt3amutations limit normal and autoreactive Tfh differentiation;2024-02-21

3. Modulating T-cell activation with antisense oligonucleotides targeting lymphocyte cytosolic protein 2;Journal of Autoimmunity;2022-07